Abstract

USP14 is a cysteine protease deubiquitinase associated with the proteasome and plays important catalytic and allosteric roles in proteasomal degradation. USP14 inhibition has been considered a therapeutic strategy for accelerating degradation of aggregation-prone proteins in neurodegenerative diseases and for inhibiting proteasome function to induce apoptotic cell death in cancers. Here we studied the effects of USP14 inhibition in mammalian cells using small molecule inhibitors and an inactive USP14 mutant C114A. Neither the inhibitors nor USP14 C114A showed consistent or significant effects on the level of TDP-43, tau or α-synuclein in HEK293T cells. However, USP14 C114A led to a robust accumulation of ubiquitinated proteins, which were isolated by ubiquitin immunoprecipitation and identified by mass spectrometry. Among these proteins we confirmed that ubiquitinated β-catenin accumulated in the cells expressing USP14 C114A with immunoblotting and immunoprecipitation experiments. The proteasome binding domain of USP14 C114A is required for its effect on ubiquitinated proteins. UCHL5 is the other cysteine protease deubiquitinase associated with the proteasome. Interestingly, the inactive mutant of UCHL5 C88A also caused an accumulation of ubiquitinated proteins in HEK293T cells but did not affect β-catenin, demonstrating USP14 but not UCHL5 has a specific effect on β-catenin. We used ubiquitin immunoprecipitation and mass spectrometry to identify the accumulated ubiquitinated proteins in UCHL5 C88A expressing cells which are mostly distinct from those identified in USP14 C114A expressing cells. Among the identified proteins are well established proteasome substrates and proteasome subunits. Besides β-catenin, we also verified with immunoblotting that UCHL5 C88A inhibits its own deubiquitination and USP14 C114A inhibits deubiquitination of two proteasomal subunits PSMC1 and PSMD4. Together our data suggest that USP14 and UCHL5 can deubiquitinate distinct substrates at the proteasome and regulate the ubiquitination of the proteasome itself which is tightly linked to its function.

Highlights

  • The ubiquitin-proteasome system (UPS) is the main protein degradation pathway in eukaryotic cells [1]

  • Inactive USP14 C114A does not change the level of TDP-43, tau or αsynuclein in HEK293T cells

  • Dose responses of 1U1 up to 100 μM (6 hours) did not affect the level of TDP-43, tau or α-synuclein (S2C and S2D Fig). b-AP15 treatment caused an accumulation of ubiquitinated proteins as previously published [29] but did not affect the level of TDP-43, tau or α-synuclein (S2E and S2F Fig)

Read more

Summary

Introduction

The ubiquitin-proteasome system (UPS) is the main protein degradation pathway in eukaryotic cells [1]. It determines the half-life of most cellular proteins, eliminates misfolded and damaged proteins, and is essential for protein homeostasis in cells. The 26S proteasome is composed of a 20S core particle (CP) containing the proteolytic chamber, and one or two 19S regulatory particles (RP) critical for substrate recognition, deubiquitination, unfolding, and translocation [5, 6]. Prior to and during substrate degradation, its ubiquitin tag must be removed, ensuring efficient substrate translocation into the proteolytic chamber and ubiquitin recycling in the cell [7, 8]. The 19S RP harbors three deubiquitinating enzymes (DUBs) including two cysteine proteases, ubiquitin-specific protease 14 (USP14 in mammals or Ubp in yeast) and ubiquitin C-terminal hydrolase L5 (UCHL5, known as UCH37), and a Zn2+-dependent metalloprotease RPN11 [9,10,11,12]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call